HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annamaria Biroccio Selected Research

Annamaria Biroccio Research Topics

Disease

47Neoplasms (Cancer)
01/2022 - 03/2002
15Melanoma (Melanoma, Malignant)
06/2016 - 05/2002
5Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2019
5Carcinogenesis
01/2019 - 02/2009
4Carcinoma (Carcinomatosis)
07/2004 - 03/2002
3Breast Neoplasms (Breast Cancer)
08/2005 - 03/2002
2Colonic Neoplasms (Colon Cancer)
10/2019 - 11/2015
2Mesothelioma
03/2011 - 12/2010
2Prostatic Neoplasms (Prostate Cancer)
09/2007 - 09/2004
1Bites and Stings (Sting)
01/2022
1Genomic Instability
01/2018
1Alcoholism (Alcohol Abuse)
10/2017
1Hypersensitivity (Allergy)
10/2017
1Rectal Neoplasms (Rectal Cancer)
01/2017
1Thymoma (Thymic Carcinoma)
03/2011
1Malignant Mesothelioma
03/2011
1Chromosome Aberrations (Chromosome Abnormalities)
09/2009
1Neoplasm Metastasis (Metastasis)
02/2009
1Ovarian Neoplasms (Ovarian Cancer)
02/2009
1Pathologic Processes
08/2005

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2003
10LigandsIBA
03/2020 - 11/2008
9Telomerase (Telomerase Reverse Transcriptase)IBA
10/2019 - 05/2002
8Pharmaceutical PreparationsIBA
01/2022 - 09/2003
8Biological ProductsIBA
10/2021 - 11/2004
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2004
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 03/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2020 - 09/2002
4Antineoplastic Agents (Antineoplastics)IBA
10/2019 - 01/2003
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2019 - 01/2003
4Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2019 - 01/2003
4EMICORONIBA
05/2017 - 12/2012
4Cisplatin (Platino)FDA LinkGeneric
07/2011 - 01/2003
3Biomarkers (Surrogate Marker)IBA
06/2020 - 12/2017
3EnzymesIBA
11/2017 - 01/2003
3PeryleneIBA
06/2016 - 03/2011
3OligodeoxyribonucleotidesIBA
07/2011 - 08/2005
3Endothelin-1 (Endothelin 1)IBA
02/2009 - 03/2002
3Hormones (Hormone)IBA
09/2007 - 03/2002
2SirtuinsIBA
01/2019 - 01/2018
2ChromatinIBA
01/2019 - 04/2011
2Messenger RNA (mRNA)IBA
06/2016 - 09/2002
2SaltsIBA
10/2014 - 11/2008
2oblimersen (G3139)IBA
07/2011 - 09/2007
2Docetaxel (Taxotere)FDA Link
09/2007 - 08/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2005 - 03/2002
2Peptides (Polypeptides)IBA
08/2002 - 03/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2002 - 03/2002
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2022
1pyridostatinIBA
01/2022
1MethyltransferasesIBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1chelidonineIBA
10/2021
1RotenoneIBA
10/2021
1ErbB Receptors (EGF Receptor)IBA
07/2020
1HMGB1 Protein (HMG1)IBA
10/2019
1NucleoproteinsIBA
01/2019
1InterferonsIBA
01/2019
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2019
1NAD (NADH)IBA
01/2018
1TrabectedinIBA
12/2017
1A-Form DNA (A-DNA)IBA
11/2017
1AcetaldehydeIBA
10/2017
1Disulfiram (Antabuse)FDA Link
10/2017
1Telomeric Repeat Binding Protein 2IBA
01/2017
1coroneneIBA
06/2016
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2014
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2014
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
03/2014
1Nucleic AcidsIBA
07/2011
1trioctyl phosphine oxide (TOPO)IBA
04/2011
1ST 1481 (Gimatecan)IBA
04/2011
1Aromatase (CYP19)IBA
03/2011
1exemestane (Aromasin)FDA Link
03/2011
1CaspasesIBA
03/2011
1Aromatase InhibitorsIBA
03/2011
1Aurora KinasesIBA
12/2010
1Aurora Kinase AIBA
12/2010
1Bromodeoxyuridine (BrdU)IBA
09/2009
1beta-ArrestinsIBA
02/2009
1beta CateninIBA
02/2009
1Endothelin A ReceptorIBA
02/2009
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2009
1ZD4054IBA
02/2009
1Growth Factor ReceptorsIBA
02/2009
1Glycogen Synthase KinasesIBA
02/2009
1Irinotecan (Camptosar)FDA LinkGeneric
11/2008
1gamma-glutamylcysteineIBA
10/2007
1Ligases (Synthetase)IBA
10/2007
1INX 6295IBA
09/2007
1Telomere-Binding ProteinsIBA
08/2006
1OligonucleotidesIBA
08/2005
1Trastuzumab (Herceptin)FDA Link
08/2005
1OGX-011IBA
08/2005
1Glycoproteins (Glycoprotein)IBA
08/2005
1Epirubicin (Ellence)FDA LinkGeneric
08/2005

Therapy/Procedure

14Therapeutics
07/2020 - 03/2002
5Drug Therapy (Chemotherapy)
01/2022 - 09/2007
3Aftercare (After-Treatment)
07/2011 - 03/2003
1Combination Drug Therapy (Combination Chemotherapy)
07/2011